This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

This study has been completed.
Information provided by:
Innovative Medical Identifier:
First received: May 2, 2007
Last updated: September 5, 2007
Last verified: September 2007
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Condition Intervention Phase
Tear Film Thickness Drug: Refresh Tears, 9582X Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)

Resource links provided by NLM:

Further study details as provided by Innovative Medical:


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  1. Normal, healthy volunteers 18 years or older
  2. Males or females
  3. Any race or ethnic background

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00469521

United States, South Carolina
Magill Research Center Institute MUSC
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Helga Sandoval, MS, MD Magill Research Center Institute MUSC
  More Information Identifier: NCT00469521     History of Changes
Other Study ID Numbers: 5304
Study First Received: May 2, 2007
Last Updated: September 5, 2007 processed this record on September 20, 2017